Amanote Research
Register
Sign In
P1.03-15 TMS Reduced Gefitinib Resistance in NSCLCs via Suppressing MAPK/Akt/Bcl-2 Pathway by Upregulation of miR-345 and miR-498
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.696
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
P. Liu
M. Lu
B. Liu
Publisher
Elsevier BV